Literature DB >> 11703537

Viral escape mechanisms--escapology taught by viruses.

M Lucas1, U Karrer, A Lucas, P Klenerman.   

Abstract

Viruses have 'studied' immunology over millions of years of coevolution with their hosts. During this ongoing education they have developed countless mechanisms to escape from the host's immune system. To illustrate the most common strategies of viral immune escape we have focused on two murine models of persistent infection, lymphocytic choriomeningitis virus (LCMV) and murine cytomegalovirus (MCMV). LCMV is a fast replicating small RNA virus with a genome prone to mutations. Therefore, LCMV escapes from the immune system mainly by two strategies: 'speed' and 'shape change'. At the opposite extreme, MCMV is a large, complex DNA virus with a more rigid genome and thus the strategies used by LCMV are no option. However, MCMV has the coding capacity for additional genes which interfere specifically with the immune response of the host. These escape strategies have been described as 'camouflage' and 'sabotage'. Using these simple concepts we describe the spectrum of viral escapology, giving credit not only to the researchers who uncovered this fascinating area of immunology but also to the viruses themselves, who still have a few lessons to teach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703537      PMCID: PMC2517780          DOI: 10.1046/j.1365-2613.2001.00204.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  125 in total

Review 1.  The liver as a site of T-cell apoptosis: graveyard, or killing field?

Authors:  I N Crispe; T Dao; K Klugewitz; W Z Mehal; D P Metz
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

2.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates.

Authors:  G Ferlazzo; C Semino; G M Spaggiari; M Meta; M C Mingari; G Melioli
Journal:  Int Immunol       Date:  2000-12       Impact factor: 4.823

5.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

Authors:  A Takaki; M Wiese; G Maertens; E Depla; U Seifert; A Liebetrau; J L Miller; M P Manns; B Rehermann
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

6.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; E J Wiertz; L Sun; K N Fish; J A Nelson; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.

Authors:  M K Spriggs; R J Armitage; M R Comeau; L Strockbine; T Farrah; B Macduff; D Ulrich; M R Alderson; J Müllberg; J I Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus.

Authors:  U Kalinke; E M Bucher; B Ernst; A Oxenius; H P Roost; S Geley; R Kofler; R M Zinkernagel; H Hengartner
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

9.  CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.

Authors:  F Lechner; N H Gruener; S Urbani; J Uggeri; T Santantonio; A R Kammer; A Cerny; R Phillips; C Ferrari; G R Pape; P Klenerman
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

10.  Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence.

Authors:  U Mahlknecht; C Deng; M C Lu; T C Greenough; J L Sullivan; W A O'Brien; G Herbein
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

View more
  32 in total

1.  Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins.

Authors:  Tomer Hertz; David Nolan; Ian James; Mina John; Silvana Gaudieri; Elizabeth Phillips; Jim C Huang; Gonzalo Riadi; Simon Mallal; Nebojsa Jojic
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

2.  Viral mutation rates: modelling the roles of within-host viral dynamics and the trade-off between replication fidelity and speed.

Authors:  Roland R Regoes; Steven Hamblin; Mark M Tanaka
Journal:  Proc Biol Sci       Date:  2012-11-07       Impact factor: 5.349

3.  Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.

Authors:  Timothy T Spear; Timothy P Riley; Gretchen E Lyons; Glenda G Callender; Jeffrey J Roszkowski; Yuan Wang; Patricia E Simms; Gina M Scurti; Kendra C Foley; David C Murray; Lance M Hellman; Rachel H McMahan; Makio Iwashima; Elizabeth Garrett-Mayer; Hugo R Rosen; Brian M Baker; Michael I Nishimura
Journal:  J Leukoc Biol       Date:  2016-02-26       Impact factor: 4.962

4.  Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus.

Authors:  Leïla Baloul; Serge Camelo; Monique Lafon
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 5.  Metabolomics Signatures of SARS-CoV-2 Infection.

Authors:  Babak Arjmand; Bagher Larijani; Sepideh Alavi-Moghadam; Peyvand Parhizkar-Roudsari; Mostafa Rezaei-Tavirani; Akram Tayanloo-Beik; Parisa Goodarzi; Neda Mehrdad; Fereshteh Mohamadi-Jahani
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression.

Authors:  Isabelle Sheridan; Oliver G Pybus; Edward C Holmes; Paul Klenerman
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  A computational method for identification of vaccine targets from protein regions of conserved human leukocyte antigen binding.

Authors:  Lars R Olsen; Christian Simon; Ulrich J Kudahl; Frederik O Bagger; Ole Winther; Ellis L Reinherz; Guang L Zhang; Vladimir Brusic
Journal:  BMC Med Genomics       Date:  2015-12-09       Impact factor: 3.063

Review 8.  Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?

Authors:  Abdellatif Bouayad
Journal:  Rev Med Virol       Date:  2021-04-01       Impact factor: 11.043

9.  Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.

Authors:  L Ponoop Prasad Patro; Chakkarai Sathyaseelan; Patil Pranita Uttamrao; Thenmalarchelvi Rathinavelan
Journal:  Infect Genet Evol       Date:  2021-06-18       Impact factor: 3.342

Review 10.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.

Authors:  Amy D Proal; Michael B VanElzakker
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.